The Effect of Escitalopram on Central Serotonergic and Dopaminergic Systems in Patients with Cervical Dystonia, and Its Relationship with Clinical Treatment Effects: A Double-Blind Placebo-Controlled Trial.

作者: Evelien Zoons , Marina A.J. Tijssen , Yasmine E.M. Dreissen , Marenka Smit , Jan Booij

DOI: 10.3390/BIOM10060880

关键词: Placebo-controlled studyGastroenterologyInternal medicineCervical dystoniaDystoniaSerotonin transporterEscitalopramSerotonin reuptake inhibitorMedicineIodobenzamideClinical Global Impression

摘要: Purpose: The pathophysiology of cervical dystonia (CD) is thought to be related changes in dopamine and serotonin levels the brain. We performed a double-blind trial with escitalopram (selective reuptake inhibitor; SSRI) patients CD. Here, we report on D2/3 receptor (D2/3R), transporter (DAT) (SERT) binding potential (BPND) after six-week treatment course or placebo. Methods: CD had [123I]FP-CIT SPECT (I-123 fluoropropyl carbomethoxy-3 beta-(4-iodophenyltropane) single-photon emission computed tomography) scans, quantify extrastriatal SERT striatal DAT, [123I]IBZM iodobenzamide SPECT) scans D2/3R BPND before six weeks either Treatment effect was evaluated Clinical Global Impression scale for dystonia, jerks psychiatric symptoms, both by physicians patients. Results: In treated placebo there were no significant differences SERT, DAT BPND. Comparing (n = 8) showed trend (p 0.13) towards lower SSRI group (median occupancy 64.6%). After escitalopram, who reported positive symptoms significantly higher compared did not experience an effect. Conclusion: Higher associated subjective

参考文章(38)
Werner Zitterl, Martin Aigner, Thomas Stompe, Karin Zitterl-Eglseer, Karin Gutierrez-Lobos, Brigitte Schmidl-Mohl, Thomas Wenzel, Ulrike Demal, Georg Zettinig, Kurt Hornik, Kenneth Thau, [123I]-β-CIT SPECT Imaging Shows Reduced Thalamus–Hypothalamus Serotonin Transporter Availability in 24 Drug-Free Obsessive-Compulsive Checkers Neuropsychopharmacology. ,vol. 32, pp. 1661- 1668 ,(2007) , 10.1038/SJ.NPP.1301290
Yolanda Zea-Ponce, John L. Neumeyer, Mitchell S. Gandelman, Robert B. Innis, Sami S. Zoghbi, Anissa Abi-Dargham, Dennis S. Charney, Paul B. Hoffer, Gabriel A. DeErausquin, Marc Laruelle, Ronald M. Baldwin, SPECT Imaging of Dopamine Transporters in Human Brain with Iodine-123-Fluoroalkyl Analogs of β-CIT The Journal of Nuclear Medicine. ,vol. 37, pp. 1129- 1133 ,(1996)
G. Tissingh, J. B. A. Habraken, A. Winogrodzka, P. Bergmans, J. C. Stoof, E. C. Wolters, J. Booij, E. A. Van Royen, A. G. M. Janssen, Imaging of Dopamine Transporters with Iodine-123-FP-CIT SPECT in Healthy Controls and Patients with Parkinson's Disease The Journal of Nuclear Medicine. ,vol. 39, pp. 1879- 1884 ,(1998)
Pia Baldinger, Georg S. Kranz, Daniela Haeusler, Markus Savli, Marie Spies, Cecile Philippe, Andreas Hahn, Anna Höflich, Wolfgang Wadsak, Markus Mitterhauser, Rupert Lanzenberger, Siegfried Kasper, Regional differences in SERT occupancy after acute and prolonged SSRI intake investigated by brain PET NeuroImage. ,vol. 88, pp. 252- 262 ,(2014) , 10.1016/J.NEUROIMAGE.2013.10.002
Meera Vaswani, Farzana Kadar Linda, Subramanyam Ramesh, Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review Progress in Neuro-Psychopharmacology and Biological Psychiatry. ,vol. 27, pp. 85- 102 ,(2003) , 10.1016/S0278-5846(02)00338-X
Walter Koch, Marcus Unterrainer, Guoming Xiong, Peter Bartenstein, Markus Diemling, Andrea Varrone, John C Dickson, Livia Tossici-Bolt, Terez Sera, Susanne Asenbaum, Jan Booij, Ozlem L Kapucu, Andreas Kluge, Morten Ziebell, Jacques Darcourt, Flavio Nobili, Marco Pagani, Swen Hesse, Thierry Vander Borght, Koen Van Laere, Klaus Tatsch, Christian La Fougere, None, Extrastriatal binding of [123I]FP-CIT in the thalamus and pons: gender and age dependencies assessed in a European multicentre database of healthy controls European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 41, pp. 1938- 1946 ,(2014) , 10.1007/S00259-014-2785-8
A. Rominger, P. Cumming, M. Brendel, G. Xiong, C. Zach, S. Karch, K. Tatsch, P. Bartenstein, C. la Fougère, W. Koch, O. Pogarell, Altered serotonin and dopamine transporter availabilities in brain of depressed patients upon treatment with escitalopram: A [123I]β-CIT SPECT study European Neuropsychopharmacology. ,vol. 25, pp. 873- 881 ,(2015) , 10.1016/J.EURONEURO.2014.12.010
Martijn Figee, Pelle de Koning, Sanne Klaassen, Nienke Vulink, Mariska Mantione, Pepijn van den Munckhof, Richard Schuurman, Guido van Wingen, Thérèse van Amelsvoort, Jan Booij, Damiaan Denys, Deep brain stimulation induces striatal dopamine release in obsessive-compulsive disorder Biological Psychiatry. ,vol. 75, pp. 647- 652 ,(2014) , 10.1016/J.BIOPSYCH.2013.06.021
Ana M. Catafau, Victor Perez, Pedro Plaza, Juan-Carlos Pascual, Santiago Bullich, Marina Suarez, Maria M. Penengo, Iluminada Corripio, Dolors Puigdemont, Monica Danus, Javier Perich, Enric Alvarez, Serotonin transporter occupancy induced by paroxetine in patients with major depression disorder: a 123I-ADAM SPECT study. Psychopharmacology. ,vol. 189, pp. 145- 153 ,(2006) , 10.1007/S00213-006-0540-Y
Henricus G Ruhé, Jan Booij, Henk C v Weert, Johannes B Reitsma, Eric J F Fransen, Martin C Michel, Aart H Schene, Evidence Why Paroxetine Dose Escalation is Not Effective in Major Depressive Disorder: A Randomized Controlled Trial With Assessment of Serotonin Transporter Occupancy Neuropsychopharmacology. ,vol. 34, pp. 999- 1010 ,(2009) , 10.1038/NPP.2008.148